Skip to main content

Table 1 Characteristics of patients with vespid or bee venom allergy

From: Quality-of-life in insect venom allergy: validation of the Turkish version of the “Vespid Allergy Quality of Life Questionnaire” (VQLQ-T)

 

Apis

Vespula

Number

81

65

Age (years)*

42.33 ± 12.58

39.2 ± 13.06

[46 (18–70)]

[38 (17–70)]

Gender

  

 Female, no (%)

34 (42 %)

33 (51 %)

 Male, no (%)

47 (58 %)

32 (49 %)

Severity of systemic reactions (%)

 Grade I

9 (11.1)

5 (7.7)

 Grade II

21 (26)

25 (38.5)

 Grade III

24 (29.6)

15 (23)

 Grade IV

27 (33.3)

20 (30.8)

Patient groups for cross-sectional validation

 New diagnosis

18 (22.2)

23(35.4)

 Recently started (up-dosing) VIT

30 (37)

18 (27.7)

 Receiving on maintenance VIT

22 (27.2)

16 (24.6)

 Stopped VIT

11 (13.6)

8 (12.3)

  1. For the variables with *, cells represent mean ± standard deviation [median (min–max)], for the others, cells represent frequency (percent). VIT venom immunotherapy